Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase

Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase
Ebos CEO John Cullity doesn't want to pre-empt regulators. (Image: supplied)
Jenny Ruth
Ebos Group's purchase of the LifeHealthcare business is unlikely to have trouble clearing competition watchdogs on either side of the Tasman since its existing medical devices business is quite small.Ebos bought the LMT and National Surgical businesses in late 2019 for A$34 million compared with the LifeHealthcare purchase price of A$1.17 billion.In August last year, it also announced the purchase of Pioneer Medical, a New Zealand-based importer and distributor of spine and major joint implants and associated surgical technologies.Ebos didn...

More Infrastructure

Air NZ crew confirm strike action
Retail

Air NZ crew confirm strike action

FAANZ president Craig Featherby said members felt they had no choice but to strike.

Staff reporters 21 Nov 2025
Reform wave reshapes energy sector as investors circle NZ
Infrastructure

Reform wave reshapes energy sector as investors circle NZ

Nearly half of surveyed offshore investors planning an acquisition.

Ian Llewellyn 21 Nov 2025
Goodman Property looks to full-year earnings growth
Infrastructure

Goodman Property looks to full-year earnings growth

The REIT lifts interim profit, as well as per-unit earnings and net tangible assets.

Andy Macdonald 20 Nov 2025
The back-to-front ferry deal
Opinion

Pattrick Smellie: The back-to-front ferry deal

Will the wharves be ready when the new ferries arrive?

Pattrick Smellie 20 Nov 2025